发明名称 Viral adjuvants
摘要 The present invention provides viral adjuvants for enhancing an immune response to an immunogen. In particular embodiments, the viral adjuvant is an alphavirus adjuvant or a Venezuelan Equine Encephalitis viral adjuvant. Also provided are compositions comprising the viral adjuvant and an immunogen, and pharmaceutical formulations comprising the viral adjuvant or compositions of the invention in a pharmaceutically acceptable carrier. Further provided are methods of producing an immune response against an immunogen in a subject comprising administering the immunogen and a viral adjuvant of the invention to the subject.
申请公布号 US8821897(B2) 申请公布日期 2014.09.02
申请号 US201012954021 申请日期 2010.11.24
申请人 The University of North Carolina at Chapel Hill 发明人 Johnston Robert E.;Thompson Joseph M.
分类号 A61K39/39;A61K39/193;A61K39/12;C07K14/005;A61K39/145;A61K39/00 主分类号 A61K39/39
代理机构 Myers Bigel Sibley & Sajovec, P.A. 代理人 Myers Bigel Sibley & Sajovec, P.A.
主权项 1. An alphavirus adjuvant comprising: a modified alphavirus genomic nucleic acid that lacks sequences encoding the alphavirus structural proteins required for production of new alphavirus particles; wherein the modified alphavirus genome does not comprise a heterologous nucleic acid sequence that encodes a polypeptide of interest or a functional untranslated RNA and the 26S promoter is inactivated or deleted.
地址 Chapel Hill NC US